<?xml version="1.0" encoding="UTF-8"?>
<ref id="B87-pharmaceutics-12-00171">
 <label>87.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Meng</surname>
    <given-names>H.</given-names>
   </name>
   <name>
    <surname>Leong</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Leong</surname>
    <given-names>K.W.</given-names>
   </name>
   <name>
    <surname>Chen</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Zhao</surname>
    <given-names>Y.</given-names>
   </name>
  </person-group>
  <article-title>Walking the line: The fate of nanomaterials at biological barriers</article-title>
  <source>Biomaterials</source>
  <year>2018</year>
  <volume>174</volume>
  <fpage>41</fpage>
  <lpage>53</lpage>
  <pub-id pub-id-type="doi">10.1016/j.biomaterials.2018.04.056</pub-id>
  <?supplied-pmid 29778981?>
  <pub-id pub-id-type="pmid">29778981</pub-id>
 </element-citation>
</ref>
